-
Beckman Coulter SARS-CoV-2 IgM Antibody Test Receives Emergency Use Authorization
americanpharmaceuticalreview
October 16, 2020
Beckman Coulter announced its Access SARS-CoV-2 Immunoglobulin M (IgM) assay has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA).
-
Celltrion COVID-19 antibody treatment to enter Phase III trial
europeanpharmaceuticalreview
October 16, 2020
Celltrion Group’s CT-P59 antibody will be tested as a COVID-19 prophylactic in a Phase III clinical trial.
-
Can an antibody 'cocktail' prevent COVID-19 infection?
worldpharmanews
October 15, 2020
In a new clinical trial, UC Davis Health will test the effectiveness and safety of REGN-COV2, the monoclonal antibody cocktail, in preventing COVID-19 in adults living with infected patients.
-
US, AstraZeneca sign pact for COVID-19 antibody treatment used to treat Trump
expresspharma
October 12, 2020
The agreement, under Operation Warp Speed, is to develop a monoclonal antibody cocktail that can prevent COVID-19, especially in high-risk population.
-
Lilly and Amgen to collaborate for manufacturing COVID-19 antibody therapies
expresspharma
September 18, 2020
Together, the companies hope to be able to produce many millions of doses even next year.
-
Tiny antibody component highly effective against SARS-COV-2 in animal studies
worldpharmanews
September 16, 2020
University of Pittsburgh School of Medicine scientists have isolated the smallest biological molecule to date that completely and specifically neutralizes the SARS-CoV-2 virus, which is the cause of COVID-19.
-
GSK, Vir Biotech to test COVID-19 antibody treatment
expresspharma
September 02, 2020
The long-acting single injection will be tested on recently diagnosed high-risk cases for its ability to prevent hospitalisation.
-
US DOJ permits six drug makers to share info about COVID-19 MAb treatments to expedite production
expresspharma
July 27, 2020
The approval granted through a business review letter from the Justice Department's antitrust division, however, has not allowed any discussion on the pricing of the treatments and production costs.
-
Neutralizing antibodies isolated from COVID-19 patients may suppress virus
worldpharmanews
July 23, 2020
Researchers at Columbia University Irving Medical Center have isolated antibodies from several COVID-19 patients that, to date, are among the most potent in neutralizing the SARS-CoV-2 virus.
-
Celltrion begins Covid-19 human clinical trial with antiviral antibody treatment
pharmaceutical-business-review
July 21, 2020
Celltrion Group has commenced phase 1 human clinical study to assess the potential of its antiviral antibody treatment for patients with Covid-19.